Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunardi

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
BMC Pediatrics|October 16, 2020
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary reportBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 1, 2020
One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate VaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
Frontiers in Digital Health|October 20, 2023
Effectiveness of an online mental health strengthening module to build resilience and overcome stress for transitional aged medical studentsFransiska Kaligis, Raden Irawati Ismail, Tjhin Wiguna, et al.
BMC Pediatrics|May 29, 2018
DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months oldHartono Gunardi, Kusnandi Rusmil, Eddy Fadlyana, et al.
Vaccines|April 27, 2024
Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in IndonesiaSharifah Shakinah, Muhammad Hafiz Aini, Rini Sekartini, et al.
BMC Pediatrics|October 18, 2023
The Cohort of Indonesian Preterm Infants for Long-term Outcomes (CIPTO) study: a protocolRinawati Rohsiswatmo, Hardya Gustada Hikmahrachim, Muhamad Azharry Rully Sjahrulla, et al.
Plos Neglected Tropical Diseases|May 3, 2018
Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian childrenAri Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Plos Neglected Tropical Diseases|June 16, 2017
Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian childrenAri Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Plos One|February 14, 2019
Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Iris Rengganis, et al.
BMC Pediatrics|December 22, 2015
The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization scheduleKusnandi Rusmil, Hartono Gunardi, Eddy Fadlyana, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
BMC Pediatrics|October 16, 2020
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary reportBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 1, 2020
One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate VaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
Frontiers in Digital Health|October 20, 2023
Effectiveness of an online mental health strengthening module to build resilience and overcome stress for transitional aged medical studentsFransiska Kaligis, Raden Irawati Ismail, Tjhin Wiguna, et al.
BMC Pediatrics|May 29, 2018
DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months oldHartono Gunardi, Kusnandi Rusmil, Eddy Fadlyana, et al.
Vaccines|April 27, 2024
Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in IndonesiaSharifah Shakinah, Muhammad Hafiz Aini, Rini Sekartini, et al.
BMC Pediatrics|October 18, 2023
The Cohort of Indonesian Preterm Infants for Long-term Outcomes (CIPTO) study: a protocolRinawati Rohsiswatmo, Hardya Gustada Hikmahrachim, Muhamad Azharry Rully Sjahrulla, et al.
Plos Neglected Tropical Diseases|May 3, 2018
Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian childrenAri Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Plos Neglected Tropical Diseases|June 16, 2017
Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian childrenAri Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Plos One|February 14, 2019
Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Iris Rengganis, et al.
BMC Pediatrics|December 22, 2015
The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization scheduleKusnandi Rusmil, Hartono Gunardi, Eddy Fadlyana, et al.
Pageof 9